Ligand validation:2J65

MYR: MYRISTIC ACID

MYR is a Ligand Of Interest in 2J65 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2J65_MYR_B_403	35%	61%	0.229	0.92	0.57	0.88	-	1	2	0	100%	0.5
2J65_MYR_B_401	19%	57%	0.301	0.897	0.55	1.06	-	2	2	0	100%	0.5
2J65_MYR_A_401	9%	59%	0.258	0.752	0.47	1.06	-	1	0	0	100%	1
1P42_MYR_B_602	40%	88%	0.195	0.905	0.09	0.57	-	-	0	0	100%	1
7OWO_MYR_D_401	88%	73%	0.088	0.962	0.45	0.59	-	-	0	0	100%	0.525
7OWU_MYR_C_101	84%	68%	0.106	0.967	0.53	0.66	-	-	1	0	100%	0.9375
5O9U_MYR_C_101	81%	63%	0.111	0.964	0.58	0.8	-	-	0	0	100%	0.9375
7A9Y_MYR_BBB_201	74%	66%	0.089	0.919	0.79	0.49	1	-	1	0	100%	1
5UR9_MYR_A_205	73%	56%	0.12	0.948	0.65	1.02	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.